WashU Expert: New method of finding drugs more important than new antibiotic itself

It was big news this week when Nature published the discovery of a new antibiotic, teixobactin. Teixobactin, which kills bacteria by a different pathway than other antibiotics, represented the first new class of antibiotics to be discovered in 30 years. But, says, Michael S. Kinch of Washington University in St. Louis, the drug itself may be less important than the way it was found.
Not all obese people develop metabolic problems linked to excess weight​​​​

Not all obese people develop metabolic problems linked to excess weight​​​​

New research demonstrates that obesity does not always go hand in hand with metabolic changes in the body that can lead to diabetes, heart disease and stroke. Washington University School of Medicine researchers found that a subset of obese people do not have common metabolic abnormalities associated with obesity, and they don’t develop them when they gain more weight.​

Wash U Expert: Drug manufacturers must be held accountable for public safety

Fourteen people have been arrested in connection with a 2012 outbreak of fungal meningitis linked to steroid injections that caused 64 deaths across the United States. The arrests, which resulted in two people being charged with 25 acts of second-degree murder, remind us that drug manufacturers must be responsible for their actions, says a noted medical ethics expert at Washington University in St. Louis.

Plax honored for work with The SPOT

Katie Plax, MD, a professor of pediatrics at the School of Medicine, has received the Dr. Corinne Walentik Leadership in Health Award from the Missouri Foundation for Health. The award, in its second year, was created to honor the late Dr. Walentik’s commitment to serving vulnerable populations.
Older Stories